Topics

MicroUDxTM: a Rapid Diagnostic Tool That Will Prevent Death and Disability From Common Infections

2020-01-19 11:04:54 | BioPortfolio

Summary

Background & Rational:

Antibiotics are a major underpinning of modern medicine. The global rise of antimicrobial resistant (AMR) organisms is a serious world health problem. With few new antimicrobial drugs on the horizon, it is imperative that we develop novel approaches to extend the service life of our existing drugs. AMR is a complex problem that is being driven by a wide range of factors. More than half of the antibiotics prescribed have no medical benefit, and outpatient visits for uncomplicated urinary tract infections (UTIs) are a major contributor to this problem. Recent studies have shown that nearly half of people treated for UTIs receive the wrong frontline drug and in 75% of patients, the duration of therapy is inappropriate. Limitations in the current diagnostic technology make it impossible to identify UTI pathogens and measure their antibiotic sensitivities during the short out-patient clinical visits that are typical for most UTI patients. These circumstances result in the inappropriate use of stronger than necessary or inappropriate antimicrobials. The aim of this study is to develop and evaluate a system that can detect bacteria in urine and find the best antibiotic in under 4 hours, thus enabling a rapid diagnosis and use of the most appropriate and cost-effective antimicrobial agent for the agent detected.

Description

Testing done in this study will be performed either on bacterial isolates stored in the microbiology laboratory at the Diagnostic and Scientific Center in Calgary, or on up to one milliliter of residual urine sample submitted to the diagnostic laboratory with a request for urine culture and sensitivity. All urine cultures will be performed and reported in accordance with standards laboratory protocols. Research testing will only be done on residual sample once patient samples are processed or reported on for clinical purposes.

During the first phase of the study, metabolic biomarkers for uropathogens will be identified using mass spectrometry on sub-cultures of frozen isolates from the diagnostic microbiology laboratory. This will include at least 50 isolates each of uropathogens consisting of but not limited to Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterobacter species, Proteus mirabilis, Citrobacter species, Staphylococcus aureus, Staphylococcus saprophyticus, Pseudomonas aeruginosa, Enterococcus species, and Candida species. Biomarkers that are present in greater than 95% of the isolates will subsequently be using the analysis of 2000 negative, and 2000 positive urine cultures. Compounds that are subsequently identified as high yield will be selected for carbon 13 labeling to service standards.

In phase II of the study, following the development of a biomarker enrichment device at the CMRF, a performance urinalysis of the device will be conducted using residual urine sample from 1000 negative and 2000 positive urine specimens as outlined above. The performance of the new device will be evaluated relative to standard cultures and urine liquid chromatography-mass spectrometry.

Following the creation of a sensitive and specific assay, a prospective study will be carried out at the diagnostic microbiology laboratory. 3000 sample submitted for urine culture will be process in parallel with the new device and standard microbiology procedures. Sensitivity, specificity and predictive value for each analyte compared to standard culture will be determined in this portion of the study. Cost calculations and performance characteristics including turnaround time of the new assay will be compared to that in the standard laboratory procedure.

Study Design

Conditions

Bacterial Urinary Tract Infection

Location

University of Calgary
Calgary
Alberta
Canada
T2N 1N4

Status

Not yet recruiting

Source

University of Calgary

Results (where available)

View Results

Links

Published on BioPortfolio: 2020-01-19T11:04:54-0500

Clinical Trials [2547 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants

Urinary tract infection (UTI) is the most common serious bacterial infection among infants. Suprapubic aspiration and bladder catheterization are considered as the gold standard by the Ame...

Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis

The purpose of this study is to compare the microbiological cure rate of doripenem versus a comparator antibiotic in the treatment of patients with complicated urinary tract infection or p...

Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)

This is a study of patients undergoing gynecologic surgery who require post-operative catheterization to determine if prophylactic antibiotic treatment decreases the risk of post-operative...

Fosfomycin i.v. for Treatment of Severely Infected Patients

The purpose of this European, multicentric, prospective, non-interventional study is to document and evaluate the efficacy and safety of the treatment of severely infected patients with in...

Febrile Urinary Tract Infection Randomized Short Treatment Trial

The purpose of this study is to determine whether a 7-day duration of antibiotic treatment of febrile urinary tract infection (FUTI) is non inferior to 14-day standard duration of treatmen...

PubMed Articles [11590 Associated PubMed Articles listed on BioPortfolio]

Maternal urinary tract infection during pregnancy and long-term infectious morbidity of the offspring.

Urinary tract infection (UTI) is a common bacterial infection in pregnant women and is associated with adverse perinatal outcomes. We sought to investigate the long-term infectious outcomes of childre...

Does a Recent Urinary Tract Infection Increase the Risk of Postprocedure Urinary Tract Infection After Onabotulinum Toxin A?

The objective of this study was to evaluate the risk of postprocedure urinary tract infection (UTI) after injection of onabotulinum toxin A (BTX-A) in women who had a UTI within 30 days before procedu...

Phage therapy administered noninvasively could be effective in thin tubes subject to episodic flow despite washout: a simulation study.

Bacteriophages (phages) have been proposed as candidates for the treatment of bacterial infections in light of emerging antibiotic-resistant microorganisms. Bacterial growth within thin tubes is a par...

Causative organism of urinary tract infection and drug resistance in children at child's Central Teaching Hospital in Baghdad City.

To identify antibiotic susceptibility and resistance of bacterial strains responsible for urinary tract infections in children.

Urinary tract infection in pediatrics: an overview.

This review aimed to provide a critical overview on the pathogenesis, clinical findings, diagnosis, imaging investigation, treatment, chemoprophylaxis, and complications of urinary tract infection in ...

Medical and Biotech [MESH] Definitions

Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.

Symptoms of disorders of the lower urinary tract including frequency, NOCTURIA; urgency, incomplete voiding, and URINARY INCONTINENCE. They are often associated with OVERACTIVE BLADDER; URINARY INCOMPETENCE; and INTERSTITIAL CYSTITIS. Lower urinary tract symptoms in males were traditionally called PROSTATISM.

The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection.

A genus of bacteria found in the human genital and urinary tract. It is considered to be a major cause of bacterial vaginosis (VAGINOSIS, BACTERIAL).

A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.

More From BioPortfolio on "MicroUDxTM: a Rapid Diagnostic Tool That Will Prevent Death and Disability From Common Infections"

Quick Search

Relevant Topics

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Searches Linking to this Trial